Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001415889-14-003779

Material agreement · Acquisition or sale completed · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading form8k-12032014_061203.htm…